Blood tests revealed a minor elevation of aspartate aminotransfer

Blood tests revealed a minor elevation of aspartate aminotransferase (133 u/l) and alanine aminotransferase (103 u/l). Serum levels of various tumor markers were within the reference range and she had negative serological tests for hepatitis B and C. An abdominal computed tomography scan showed a nodular lesion in segment 3 of the liver that showed a target-like appearance with a low-attenuation rim (Figure 1). With magnetic resonance imaging (MRI), there was a drop in signal in the peripheral area of the lesion

on the opposed-phase T1-weighted image (Figure 2, left) but not on the in-phase T1-weighted image (Figure 2, right). The patient underwent a percutaneous biopsy with ultrasound control. Histological high throughput screening assay evaluation revealed macrovesicular and microvesicular RO4929097 datasheet steatosis, ballooning degeneration with Mallory bodies and perisinusoidal fibrosis consistent with focal steatohepatitis. Over recent years, there has been increasing interest in the effect of cancer therapy on the non-tumor bearing liver. These changes are more common with chemotherapy but have also been described with drugs such as tamoxifen. The most frequent change is that of a diffuse fatty liver.

However, fatty change can also be focal and may mimic a metastasis as in the above patient. These areas of focal steatosis are mostly found in segments 3 and 4. This distribution has been attributed to small areas in the liver that lack portal venous inflow. However, lack of portal venous inflow has also been used to explain areas of “fat-sparing”. After cessation of chemotherapy, diffuse fatty change is at check details least partially reversible in the majority of patients but the natural history of focal fatty change remains unclear. Images in the above patient illustrate the helpful role of CT and MRI in the differentiation of focal steatosis from liver metastases. With focal steatosis, there is a low attenuation area on unenhanced

CT while, with MRI, opposed-phase T1-weighted images show signal loss when compared with the in-phase images. In contrast, there is no signal loss with opposed-phase T1 images in patients with typical metastases. Contributed by “
“We read with great interest the article by Bruce et al. regarding the effect in a mouse model of maternal high-fat feeding on the development of nonalcoholic fatty liver disease (NAFLD) in adult offspring.1 The authors observed that maternal fat intake contributes toward the NAFLD progression in adult offspring, which is mediated through impaired hepatic mitochondrial metabolism. Although the authors reported only female mice data because their data from males and females showed the same pattern, we consider that some issues deserve further discussion.

Comments are closed.